Examiner Wax Robert A (SPE)

1615-WAX-ROBERT-A

Employment Information

Art Unit:1615 — Drug, bio-affecting and body treating compositions
Group:1610 — Pharmaceutical and Agricultural Compositions; Plant Growth Regulating Compositions: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs; In vivo Diagnostic Agents
Classes: 424 — Drug, bio-affecting and body treating compositions
435 — Chemistry: molecular biology and microbiology
530 — Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
504 — Plant protecting and regulating compositions
514 — Drug, bio-affecting and body treating compositions
600 — Surgery
428 — Stock material or miscellaneous articles
Phone:(571) 272-0623
Email:robert.wax@uspto.gov
Location:VA 22314
Title:Supvy Pat Examnr Gen Chem
Service:23 years
Grade:GS-15

Grant Rate and Difficulty Ranking

97
3-Year Grant rate: 4% over 23 cases
Difficulty: Extremely Hard
Difficulty Percentile: 97th

With Examiner Wax (SPE), you have a 4% chance of getting an issued patent by 3 years after the first office action. Examiner Wax (SPE) is an extremely hard examiner and in the 97th percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Wax (SPE), where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1615

Examiner Wax (SPE)'s grant rate is lower than that of Art Unit 1615 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Wax (SPE) 0.5
Art Unit 1615 1.8

Interview Benefit

Grant Rate without Interview

Examiner Wax (SPE) has granted 1 of 23 cases without any applicant-requested interviews for a grant rate of 4%.

Grant Rate with Interview

Examiner Wax (SPE) has granted 0 of 0 cases with at least one applicant-requested interview for a grant rate of 0%.

Interview Benefit

With Examiner Wax (SPE), conducting an interview decreases your chance of getting a patent granted by 100%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
18580570 Protection Of Biological Species From Degradation Rejection information available with a Premium Stats subscription. See our pricing. Patented View
18468590 Quality Control Substance For Use In The Analysis Of Erythrocytes Patented View
18258009 Hair Conditioning Composition For Improved Deposition Abandoned View
17753344 Acrylate And Silicone-Free Cosmetic O/w Emulsion Abandoned View
18026831 Method For Purification Of Recombinant Proteins Patented View
18003540 A Cream Composition With Herbal Extract And Production Method Thereof Abandoned View
18271773 Primary Gastrointestinal Stromal Tumor Cell Culture Medium, Culture Method And Application Thereof Patented View
18041576 Methods Of Producing Animal-Free Casein Compositions, Casein Compositions And Use Of Same Patented View
17909829 Multilayer Protective Antimicrobial Mask Comprising Nanofiber Membrane Abandoned View
18175303 Activating Mitotic Checkpoint Control Mechanisms Patented View
17636158 Soft Capsule Containing Tyndalized Bacteria In Film Patented View
18177931 Foreign Substance Introduction Construct And Use Thereof Patented View
17263041 Haemostatic Gel Composition And Its Process Of Preparation Abandoned View
17190773 Compositions And Methods For Repelling Coleopterans Abandoned View
16767005 Wound-Treating Absorbent Abandoned View
17873553 Hydrogel Devices And Methods Of Making And Use Thereof Patented View
16762384 Biomimetic Pro-Regenerative Scaffolds And Methods Of Use Thereof Abandoned View
17254311 Fibrous Wound Dressing Comprising An Antiseptic Abandoned View
16137155 Polymer-Lipid Hybrid Nanoparticles Of Capecitabine Utilizing Micromixing And Capecitabine Amphiphilic Properties Abandoned View
17085302 Manufacturing Device For Gelatin Capsule Abandoned View
17333345 Methods And Compositions For Reversing Or Mitigating Skin Aging Patented View
17408881 Escalating Dosing Regimen For Effecting Weight Loss And Treating Obesity Abandoned View
17408883 Low Dose Topiramate/phentermine Composition And Methods Of Use Thereof Abandoned View
17570670 Method For Treating Cancerous And Pre-Cancerous Skin Patented View
16343652 Anti-Microbial Articles Abandoned View
16096955 Aerosol Gel Composition Abandoned View
16159175 Cosmetic Composition Abandoned View
16267238 Pharmaceutical Compositions Abandoned View
16796409 Osmotic Drug Delivery System Abandoned View
15845608 Sugar-Based Dispersion Abandoned View
15850308 Bone Filler Composition Abandoned View
16874601 Treatment Of Cancer Abandoned View
16463320 Solid Oral Composition Containing Dyes Abandoned View
15945838 Body Oil Candle Abandoned View
16496522 Implantable And Removable Drug Delivery Device Abandoned View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.

Loading...